Bio Protocol vs DefiTuna — how do they compare? Bio Protocol trades at Rp516.9 (market cap Rp1,15T, Rp264,79M 24h volume), while DefiTuna trades at Rp74.46 (market cap --, Rp85,25jt 24h volume). The key difference: Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while DefiTuna's keeps growing, and Bio Protocol is more actively traded (Rp264,79M versus Rp85,25jt). Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and DefiTuna for 8 Days on average.
| BIO | TUNA | |
|---|---|---|
Market Cap | Rp1,15T | -- |
Volume (24h) | Rp264,79M | Rp85,25jt |
Circulating Supply | 2,2B / 3,3B BIO (68%) | -- |
Typical Hold Time | 16 Days | 8 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
DefiTuna (TUNA) is a cryptocurrency with a maximum supply of 1 million tokens. Current price and market data are unavailable, but the average hold time of 8 days suggests short-term trading activity. No recent technical or fundamental developments are reported, indicating limited network momentum.
Outlook: TUNA faces challenges due to lack of price visibility and ecosystem updates. Key risks include low liquidity and regulatory uncertainty. Opportunities may arise from future protocol upgrades or exchange listings, but current data gaps warrant caution for investors.
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →DefiTuna is a DeFi infrastructure layer for leveraged liquidity on Solana. Now powered by Fusion AMM—an on-chain model combining concentrated liquidity and transparent limit orders—it unifies lending, leverage, and AMMs to enable capital-efficient trading and liquidity strategies.
Read more on TUNA →